ISSN:

Journal Home

Journal Guideline

Assay and Drug Development Technologies Q3 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Assay and Drug Development Technologies is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 65. It has an SJR impact factor of 0,317 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,317.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q3) Molecular Medicine (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,317

SJR Impact factor

65

H Index

32

Total Docs (Last Year)

126

Total Docs (3 years)

1530

Total Refs

234

Total Cites (3 years)

118

Citable Docs (3 years)

1.61

Cites/Doc (2 years)

47.81

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Antibiotics Q3
Current molecular pharmacology Q3
Iranian Journal of Basic Medical Sciences Q3
Biomarkers in Medicine Q3
International Journal of Peptide Research and Therapeutics Q3

Compare this journals